CRISPR-Cas9基因編輯系統於三陰性乳癌治療上之應用(分子機轉與動物實驗之驗證)!! Archives of Pharmacal Research 2024 Nov 1 (SCI; IF = 6.9; Rank = 4% by IF in Pharmacology and Pharmacy).

Lo, Y.L.*, Hong, C.J., Wang, C.S., Yang, C.P. Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition. Archives of Pharmacal Research 2024 Nov 1. doi: 10.1007/s12272-024-01514-0. Online ahead of print (SCI; IF = 6.9; Rank = 4% by IF in Pharmacology & Pharmacy).

Shared link:

https://rdcu.be/dYMSm